BEST UNLIMITED TURBO LONG CERTIFICATE - DAVITA | Market Closed - Euronext Paris 12:30:01 2024-05-10 EDT | ||
| 2.545 EUR | +0.39% |
|
| Current month | -1.91% | ||
| 1 month | +8.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
DAVITA INC.
Latest news about DAVITA INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 2.565 | +1.18% | 37 |
| 24-05-09 | 2.535 | +2.01% | 35 |
| 24-05-08 | 2.485 | -1.19% | 43 |
| 24-05-07 | 2.515 | 0.00% | 48 |
| 24-05-06 | 2.515 | +5.45% | 46 |
Real-time Euronext Paris
Last update May 10, 2024 at 12:30 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | DAVITA INC. |
| Issuer | 
Société Générale
|
| C821S | |
| ISIN | DE000SU2AXD5 |
| Date issued | 2023-11-16 |
| Strike | 84.55 $ |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.59 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.19 € |
|---|---|
| Lowest since issue | 0.61 € |
Company Profile
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows:
- supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad;
- other (4.7%).
Sector
-
Consensus: DaVita Inc.
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
137.5
USD
Average target price
141.1
USD
Spread / Average Target
+2.58%
- Stock Market
- Certificates
- C821S Certificat